Mariner
AVXL icon

Mariner’s Anavex Life Sciences AVXL Stock Holding History

Mariner’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$174K Buy
67,135
+14,214
+27% +$42.1K ﹤0.01% 3199
2026
Q1 		$162K Buy
52,921
+14,100
+36% +$61.1K ﹤0.01% 3217
2025
Q4 		$138K Buy
38,821
+12,465
+47% +$76.4K ﹤0.01% 3267
2025
Q3 		$235K Buy
+26,356
New +$267K ﹤0.01% 3028
2024
Q2 		– Sell
-10,919
Closed -$55.6K – 3166
2024
Q1 		$55.6K Buy
+10,919
New +$61.5K ﹤0.01% 3015

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Mariner's AVXL Position: Q2 2026 in Review

Mariner increased its Anavex Life Sciences (AVXL) stake by 27% in Q2 2026, buying an estimated $42.1K and bringing the position to 67,135 shares worth $174K. The position accounts for ﹤0.01% of the portfolio, ranked #3199.

Mariner first reported a position in AVXL in Q1 2024 and has held it in 5 quarters since. The position peaked at $235K in Q3 2025. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Mariner held 67,135 shares of Anavex Life Sciences worth $174K as of Q2 2026.
  • Mariner bought 14,214 Anavex Life Sciences shares in Q2 2026, an estimated $42.1K.
  • Anavex Life Sciences made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #3199 holding.
  • Mariner first reported a position in Anavex Life Sciences in Q1 2024 and has held it in 5 quarters since.
  • Mariner's Anavex Life Sciences position peaked at $235K in Q3 2025.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.